SCHEMBL4412682

SCHEMBL4412682

O=C(O)CCCCCCCCC=Cc1ccncc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.67
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
ALDH1A1 P00352 8/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
F7 P08709 5/20 0.46
F3 P13726 5/20 0.46
CYP19A1 P11511 3/20 0.46
PPARG P37231 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL849354 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL11606213 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL8093649 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL849353 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL8093646 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL9303907 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5176079 0.85 TBXAS1 (0.68) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL850920 0.83 TBXAS1 (0.69) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL850919 0.83 TBXAS1 (0.69) TBXAS1HDAC3HDAC4HDAC1HDAC7
SCHEMBL6517314 0.82 ALDH1A1 (0.48) TBXAS1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1691845-A4 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE BRISTOL MYERS SQUIBB PHARMA CO (US) 2009-02-25 EP disclosed
EP-1691845-A1 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE Bristol-Myers Squibb Pharma Company (US) 2006-08-23 EP disclosed
WO-2005023314-A1 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-03-17 WO disclosed